Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Neurofibromatosis » Country Statistics
 

Statistics by Country for Neurofibromatosis

Incidence (annual) of Neurofibromatosis:

about 1 in 30001.

Incidence Rate for Neurofibromatosis: approx 1 in 3,000 or 0.03% or 90,666 people in USA [about data] Extrapolation of Incidence Rate for Neurofibromatosis to Countries and Regions: WARNING! EXTRAPOLATION ONLY. NOT BASED ON COUNTRY-SPECIFIC DATA SOURCES. The following table attempts to extrapolate the above incidence rate for Neurofibromatosis to the populations of various countries and regions. As discussed above, these incidence extrapolations for Neurofibromatosis are only estimates and may have very limited relevance to the actual incidence of Neurofibromatosis in any region:

Country/Region Extrapolated Incidence Population Estimated Used
Neurofibromatosis in North America (Extrapolated Statistics)
USA 97,885 293,655,4052
Canada 10,835 WARNING! (Details) 32,507,8743
Mexico 34,986 WARNING! (Details) 104,959,5943
Neurofibromatosis in Central America (Extrapolated Statistics)
Belize 90 WARNING! (Details) 272,9453
Guatemala 4,760 WARNING! (Details) 14,280,5963
Nicaragua 1,786 WARNING! (Details) 5,359,7593
Neurofibromatosis in Caribbean (Extrapolated Statistics)
Puerto Rico 1,299 WARNING! (Details) 3,897,9603
Neurofibromatosis in South America (Extrapolated Statistics)
Brazil 61,367 WARNING! (Details) 184,101,1093
Chile 5,274 WARNING! (Details) 15,823,9573
Colombia 14,103 WARNING! (Details) 42,310,7753
Paraguay 2,063 WARNING! (Details) 6,191,3683
Peru 9,181 WARNING! (Details) 27,544,3053
Venezuela 8,339 WARNING! (Details) 25,017,3873
Neurofibromatosis in Northern Europe (Extrapolated Statistics)
Denmark 1,804 WARNING! (Details) 5,413,3923
Finland 1,738 WARNING! (Details) 5,214,5123
Iceland 97 WARNING! (Details) 293,9663
Sweden 2,995 WARNING! (Details) 8,986,4003
Neurofibromatosis in Western Europe (Extrapolated Statistics)
Britain (United Kingdom) 20,090 WARNING! (Details) 60,270,708 for UK3
Belgium 3,449 WARNING! (Details) 10,348,2763
France 20,141 WARNING! (Details) 60,424,2133
Ireland 1,323 WARNING! (Details) 3,969,5583
Luxembourg 154 WARNING! (Details) 462,6903
Monaco 10 WARNING! (Details) 32,2703
Netherlands (Holland) 5,439 WARNING! (Details) 16,318,1993
United Kingdom 20,090 WARNING! (Details) 60,270,7083
Wales 972 WARNING! (Details) 2,918,0003
Neurofibromatosis in Central Europe (Extrapolated Statistics)
Austria 2,724 WARNING! (Details) 8,174,7623
Czech Republic 415 WARNING! (Details) 1,0246,1783
Germany 27,474 WARNING! (Details) 82,424,6093
Hungary 3,344 WARNING! (Details) 10,032,3753
Liechtenstein 11 WARNING! (Details) 33,4363
Poland 12,875 WARNING! (Details) 38,626,3493
Slovakia 1,807 WARNING! (Details) 5,423,5673
Slovenia 670 WARNING! (Details) 2,011,473 3
Switzerland 2,483 WARNING! (Details) 7,450,8673
Neurofibromatosis in Eastern Europe (Extrapolated Statistics)
Belarus 3,436 WARNING! (Details) 10,310,5203
Estonia 447 WARNING! (Details) 1,341,6643
Latvia 768 WARNING! (Details) 2,306,3063
Lithuania 1,202 WARNING! (Details) 3,607,8993
Russia 47,991 WARNING! (Details) 143,974,0593
Ukraine 15,910 WARNING! (Details) 47,732,0793
Neurofibromatosis in the Southwestern Europe (Extrapolated Statistics)
Azerbaijan 2,622 WARNING! (Details) 7,868,3853
Portugal 3,508 WARNING! (Details) 10,524,1453
Spain 13,426 WARNING! (Details) 40,280,7803
Georgia 1,564 WARNING! (Details) 4,693,8923
Neurofibromatosis in the Southern Europe (Extrapolated Statistics)
Italy 19,352 WARNING! (Details) 58,057,4773
Greece 3,549 WARNING! (Details) 10,647,5293
Neurofibromatosis in the Southeastern Europe (Extrapolated Statistics)
Albania 1,181 WARNING! (Details) 3,544,8083
Bosnia and Herzegovina 135 WARNING! (Details) 407,6083
Bulgaria 2,505 WARNING! (Details) 7,517,9733
Croatia 1,498 WARNING! (Details) 4,496,8693
Macedonia 680 WARNING! (Details) 2,040,0853
Romania 7,451 WARNING! (Details) 22,355,5513
Serbia and Montenegro 3,608 WARNING! (Details) 10,825,9003
Neurofibromatosis in Northern Asia (Extrapolated Statistics)
Mongolia 917 WARNING! (Details) 2,751,3143
Neurofibromatosis in Central Asia (Extrapolated Statistics)
Kazakhstan 5,047 WARNING! (Details) 15,143,7043
Tajikistan 2,337 WARNING! (Details) 7,011,556 3
Uzbekistan 8,803 WARNING! (Details) 26,410,4163
Neurofibromatosis in Eastern Asia (Extrapolated Statistics)
China 432,949 WARNING! (Details) 1,298,847,6243
Hong Kong s.a.r. 2,285 WARNING! (Details) 6,855,1253
Japan 42,444 WARNING! (Details) 127,333,0023
Macau s.a.r. 148 WARNING! (Details) 445,2863
North Korea 7,565 WARNING! (Details) 22,697,5533
South Korea 16,077 WARNING! (Details) 48,233,7603
Taiwan 7,583 WARNING! (Details) 22,749,8383
Neurofibromatosis in Southwestern Asia (Extrapolated Statistics)
Turkey 22,964 WARNING! (Details) 68,893,9183
Neurofibromatosis in Southern Asia (Extrapolated Statistics)
Afghanistan 9,504 WARNING! (Details) 28,513,6773
Bangladesh 47,113 WARNING! (Details) 141,340,4763
Bhutan 728 WARNING! (Details) 2,185,5693
India 355,023 WARNING! (Details) 1,065,070,6073
Pakistan 53,065 WARNING! (Details) 159,196,3363
Sri Lanka 6,635 WARNING! (Details) 19,905,1653
Neurofibromatosis in Southeastern Asia (Extrapolated Statistics)
East Timor 339 WARNING! (Details) 1,019,2523
Indonesia 79,484 WARNING! (Details) 238,452,9523
Laos 2,022 WARNING! (Details) 6,068,1173
Malaysia 7,840 WARNING! (Details) 23,522,4823
Philippines 28,747 WARNING! (Details) 86,241,6973
Singapore 1,451 WARNING! (Details) 4,353,8933
Thailand 21,621 WARNING! (Details) 64,865,5233
Vietnam 27,554 WARNING! (Details) 82,662,8003
Neurofibromatosis in the Middle East (Extrapolated Statistics)
Gaza strip 441 WARNING! (Details) 1,324,9913
Iran 22,501 WARNING! (Details) 67,503,2053
Iraq 8,458 WARNING! (Details) 25,374,6913
Israel 2,066 WARNING! (Details) 6,199,0083
Jordan 1,870 WARNING! (Details) 5,611,2023
Kuwait 752 WARNING! (Details) 2,257,5493
Lebanon 1,259 WARNING! (Details) 3,777,2183
Saudi Arabia 8,598 WARNING! (Details) 25,795,9383
Syria 6,005 WARNING! (Details) 18,016,8743
United Arab Emirates 841 WARNING! (Details) 2,523,9153
West Bank 770 WARNING! (Details) 2,311,2043
Yemen 6,674 WARNING! (Details) 20,024,8673
Neurofibromatosis in Northern Africa (Extrapolated Statistics)
Egypt 25,372 WARNING! (Details) 76,117,4213
Libya 1,877 WARNING! (Details) 5,631,5853
Sudan 13,049 WARNING! (Details) 39,148,1623
Neurofibromatosis in Western Africa (Extrapolated Statistics)
Congo Brazzaville 999 WARNING! (Details) 2,998,0403
Ghana 6,919 WARNING! (Details) 20,757,0323
Liberia 1,130 WARNING! (Details) 3,390,6353
Niger 3,786 WARNING! (Details) 11,360,5383
Nigeria 5,916 WARNING! (Details) 12,5750,3563
Senegal 3,617 WARNING! (Details) 10,852,1473
Sierra leone 1,961 WARNING! (Details) 5,883,8893
Neurofibromatosis in Central Africa (Extrapolated Statistics)
Central African Republic 1,247 WARNING! (Details) 3,742,4823
Chad 3,179 WARNING! (Details) 9,538,5443
Congo kinshasa 19,439 WARNING! (Details) 58,317,0303
Rwanda 2,746 WARNING! (Details) 8,238,6733
Neurofibromatosis in Eastern Africa (Extrapolated Statistics)
Ethiopia 23,778 WARNING! (Details) 71,336,5713
Kenya 10,994 WARNING! (Details) 32,982,1093
Somalia 2,768 WARNING! (Details) 8,304,6013
Tanzania 12,023 WARNING! (Details) 36,070,7993
Uganda 8,796 WARNING! (Details) 26,390,2583
Neurofibromatosis in Southern Africa (Extrapolated Statistics)
Angola 3,659 WARNING! (Details) 10,978,5523
Botswana 546 WARNING! (Details) 1,639,2313
South Africa 14,816 WARNING! (Details) 44,448,4703
Swaziland 389 WARNING! (Details) 1,169,2413
Zambia 3,675 WARNING! (Details) 11,025,6903
Zimbabwe 1,223 WARNING! (Details) 1,2671,8603
Neurofibromatosis in Oceania (Extrapolated Statistics)
Australia 6,637 WARNING! (Details) 19,913,1443
New Zealand 1,331 WARNING! (Details) 3,993,8173
Papua New Guinea 1,806 WARNING! (Details) 5,420,2803

About extrapolations of prevalence and incidence statistics for Neurofibromatosis:

WARNING! EXTRAPOLATED STATISTICS ONLY! Not based on data sources from individual countries. These statistics are calculated extrapolations of various prevalence or incidence rates against the populations of a particular country or region. The statistics used for prevalence/incidence of Neurofibromatosis are typically based on US, UK, Canadian or Australian prevalence or incidence statistics, which are then extrapolated using only the population of the other country. This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences across the various countries and regions for which the extrapolated Neurofibromatosis statistics below refer to. The extrapolation does not use data sources or statistics about any country other than its population. As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication) as to the actual prevalence or incidence of Neurofibromatosis in that region. These statistics are presented only in the hope that they may be interesting to some people.

About prevalence and incidence statistics in general for Neurofibromatosis:

The word 'prevalence' of Neurofibromatosis usually means the estimated population of people who are managing Neurofibromatosis at any given time (i.e. people with Neurofibromatosis). The term 'incidence' of Neurofibromatosis means the annual diagnosis rate, or the number of new cases of Neurofibromatosis diagnosed each year (i.e. getting Neurofibromatosis). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.



Footnotes:
1. Pathophysiology of Disease, Stephen J. McPhee, Vishwanash R. Lingappa, Willim F. Ganong, Jack D. Lang, Prentice Hall, 1995
2. US Census Bureau, Population Estimates, 2004
3. US Census Bureau, International Data Base, 2004
 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise